3rd Quarter - Amendment

CORNERSTONE GOVERNMENT AFFAIRS, INC. for VYRIPHARM ENTERPRISES, INC.

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 18, 2021 $30,000 Replaced
3rd Quarter - Amendment (this page) Jan 21, 2022 $30,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Policies and regulations associated with testing, tracing and tracking of cannabinoids.

LobbyistCovered position, as disclosed
JOSEPH BISCHOFF —
TONY ESSALIH COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)
ELLIOTT FLAGGS —

Contacted: Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Policies and regulations associated with testing, tracing and tracking of cannabinoids.

LobbyistCovered position, as disclosed
JOSEPH BISCHOFF —
TONY ESSALIH COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)
ELLIOTT FLAGGS —

Contacted: HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); SENATE

Food Industry (safety, labeling, etc.) FOO

Policies and regulations associated with testing, tracing and tracking of cannabinoids.

LobbyistCovered position, as disclosed
JOSEPH BISCHOFF —
TONY ESSALIH COS, LD, LA House Member Office (Culberson), LA House Member Office (Archer), SA House Member Office (Hastings), Intern House Member Office (Bliley)
ELLIOTT FLAGGS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Office of Natl Drug Control Policy (NDCP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.